Use of oral contraceptives reduces the risk of development of rheumatoid arthritis (RA)

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1432-1433, 2004-01, pp. : 19-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Guidelines on the use of anti-tumour necrosis factor (TNF) therapies in patients with rheumatoid arthritis (RA) have been updated

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 475, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Short-term leflunomide effectively treats active rheumatoid arthritis (RA) in everyday clinical use

By  

Inpharma, Vol. 1, Iss. 1430, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Oral contraceptives and the risk of thrombosis and atherosclerosis

By Barton Matthias   Dubey Raghvendra K   Traupe Tobias  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 3, 2002-03 ,pp. : 329-332

Informa Healthcare

Access to resources Recommend Favorite

Oral contraceptives: VT risk quantified

By  

Reactions Weekly, Vol. 1, Iss. 1266, 2009-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Oral contraceptives and risk of systemic lupus erythematosus

By  

Reactions Weekly, Vol. 1, Iss. 1254, 2009-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite